MDA SPACE LTD (MDA.CA) Fundamental Analysis & Valuation

TSX:MDA • CA55293N1096

Current stock price

42.37 CAD
+0.38 (+0.9%)
Last:

This MDA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDA.CA Profitability Analysis

1.1 Basic Checks

  • MDA had positive earnings in the past year.
  • In the past year MDA had a positive cash flow from operations.
  • Each year in the past 5 years MDA has been profitable.
  • Each year in the past 5 years MDA had a positive operating cash flow.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.23%, MDA is doing worse than 69.23% of the companies in the same industry.
  • MDA has a Return On Equity of 8.01%. This is amongst the best in the industry. MDA outperforms 84.62% of its industry peers.
  • With a Return On Invested Capital value of 5.52%, MDA is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
  • MDA had an Average Return On Invested Capital over the past 3 years of 4.56%. This is below the industry average of 9.52%.
  • The last Return On Invested Capital (5.52%) for MDA is above the 3 year average (4.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROIC 5.52%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • The Profit Margin of MDA (6.64%) is worse than 61.54% of its industry peers.
  • MDA's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 9.66%, MDA is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of MDA has declined.
  • MDA has a Gross Margin of 25.09%. This is in the better half of the industry: MDA outperforms 69.23% of its industry peers.
  • MDA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MDA.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
  • MDA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MDA has been increased compared to 5 years ago.
  • MDA has a worse debt/assets ratio than last year.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.09 indicates that MDA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.09, MDA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • MDA has a debt to FCF ratio of 3.11. This is a good value and a sign of high solvency as MDA would need 3.11 years to pay back of all of its debts.
  • The Debt to FCF ratio of MDA (3.11) is better than 84.62% of its industry peers.
  • MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of MDA (0.29) is better than 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Altman-Z 2.09
ROIC/WACC0.64
WACC8.64%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • MDA has a Current Ratio of 0.47. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.47, MDA is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.45 indicates that MDA may have some problems paying its short term obligations.
  • The Quick ratio of MDA (0.45) is worse than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.45
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MDA.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 88.57% over the past year.
  • The Earnings Per Share has been growing by 81.71% on average over the past years. This is a very strong growth
  • MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.21%.
  • MDA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 40.76% yearly.
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%

3.2 Future

  • MDA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.39% yearly.
  • The Revenue is expected to grow by 11.69% on average over the next years. This is quite good.
EPS Next Y14.58%
EPS Next 2Y14.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.07%
Revenue Next 2Y12.84%
Revenue Next 3Y11.69%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. MDA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • MDA is valuated quite expensively with a Price/Earnings ratio of 32.10.
  • Based on the Price/Earnings ratio, MDA is valued a bit more expensive than 61.54% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.78. MDA is around the same levels.
  • A Price/Forward Earnings ratio of 28.01 indicates a quite expensive valuation of MDA.
  • MDA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. MDA is more expensive than 61.54% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, MDA is valued at the same level.
Industry RankSector Rank
PE 32.1
Fwd PE 28.01
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDA indicates a slightly more expensive valuation: MDA is more expensive than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 40.57
EV/EBITDA 18.67
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDA does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as MDA's earnings are expected to grow with 14.39% in the coming years.
PEG (NY)2.2
PEG (5Y)N/A
EPS Next 2Y14.39%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDA.CA Dividend Analysis

5.1 Amount

  • MDA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDA.CA Fundamentals: All Metrics, Ratios and Statistics

MDA SPACE LTD

TSX:MDA (4/10/2026, 7:00:00 PM)

42.37

+0.38 (+0.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners37.75%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap5.36B
Revenue(TTM)1.63B
Net Income(TTM)108.50M
Analysts80
Price Target55.15 (30.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-40.3%
Max EPS beat(2)13%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)11.19%
EPS beat(12)10
Avg EPS beat(12)26.46%
EPS beat(16)13
Avg EPS beat(16)60.97%
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)0.35%
Max Revenue beat(2)6.49%
Revenue beat(4)3
Avg Revenue beat(4)3.37%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)6.87%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)2.95%
Revenue beat(16)12
Avg Revenue beat(16)2.63%
PT rev (1m)14.44%
PT rev (3m)35.37%
EPS NQ rev (1m)-10.68%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.76%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)2.01%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 32.1
Fwd PE 28.01
P/S 3.28
P/FCF 40.57
P/OCF 13.15
P/B 3.96
P/tB N/A
EV/EBITDA 18.67
EPS(TTM)1.32
EY3.12%
EPS(NY)1.51
Fwd EY3.57%
FCF(TTM)1.04
FCFY2.46%
OCF(TTM)3.22
OCFY7.6%
SpS12.91
BVpS10.71
TBVpS-2.55
PEG (NY)2.2
PEG (5Y)N/A
Graham Number17.84
Profitability
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROCE 7.74%
ROIC 5.52%
ROICexc 5.97%
ROICexgc 53.8%
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
FCFM 8.09%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
ROICexc(3y)4.93%
ROICexc(5y)3.95%
ROICexgc(3y)28.38%
ROICexgc(5y)20.74%
ROCE(3y)6.39%
ROCE(5y)5.17%
ROICexgc growth 3Y61.99%
ROICexgc growth 5YN/A
ROICexc growth 3Y16.02%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Debt/EBITDA 1.31
Cap/Depr 195.88%
Cap/Sales 16.86%
Interest Coverage 10.52
Cash Conversion 136.56%
Profit Quality 121.75%
Current Ratio 0.47
Quick Ratio 0.45
Altman-Z 2.09
F-Score5
WACC8.64%
ROIC/WACC0.64
Cap/Depr(3y)221.3%
Cap/Depr(5y)203.76%
Cap/Sales(3y)19.79%
Cap/Sales(5y)21.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
EPS Next Y14.58%
EPS Next 2Y14.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%
Revenue Next Year13.07%
Revenue Next 2Y12.84%
Revenue Next 3Y11.69%
Revenue Next 5YN/A
EBIT growth 1Y47.75%
EBIT growth 3Y28.37%
EBIT growth 5YN/A
EBIT Next Year118.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.51%
FCF growth 3YN/A
FCF growth 5Y25.11%
OCF growth 1Y-50.04%
OCF growth 3Y92.64%
OCF growth 5Y48.51%

MDA SPACE LTD / MDA.CA Fundamental Analysis FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 4 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 1 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Overvalued.


How profitable is MDA SPACE LTD (MDA.CA) stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MDA stock?

The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 32.1 and the Price/Book (PB) ratio is 3.96.


Can you provide the expected EPS growth for MDA stock?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 14.58% in the next year.